10 Most Shorted Penny Stocks to Buy
In this article, we will take a look at some of the most shorted penny stocks that currently appear highly attractive with impressive upside potential.
Anavex Life Sciences Corp. (AVXL)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 1,209,570 | $4,306,069 | +60% | 0.01% |
| 2. | 707,300 | $2,517,988 | +81% | 0% | |
| 3. | Point72 Asset Management Steve Cohen | 278,018 | $989,744 | 0% | |
| 4. | 222,100 | $790,676 | +176% | 0% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 182,190 | $648,595 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.64 | 2,835 | $10,319.40 | 5,000 | 2024-06-14 | Filing | |
| $4.52 | 5,000 | $22,600.00 | 5,000 | 2024-05-15 | Filing | |
| $10.93 | 1,000 | $10,930.00 | 2,165 | 2021-05-17 | Filing | |
| $12.97 | 165 | $2,140.05 | 1,165 | 2021-02-19 | Filing | |
| $12.62 | 1,000 | $12,620.00 | 1,000 | 2021-02-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.11 | 73,380 | $374,971.80 | 1,250,210 | 2024-03-28 | Filing | |
| $7.98 | 268,000 | $2,139,310.00 | 1,018,210 | 2023-06-28 | Filing | |
| $9.06 | 50,000 | $453,000.00 | 1,306,458 | 2022-05-25 | Filing | |
| $26.00 | 51,620 | $1,342,120.00 | 1,018,210 | 2021-06-29 | Filing | |
| $26.53 | 166,696 | $4,422,444.88 | 22,963 | 2021-06-29 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 499,700 | $1,534,079 | 0.01% | |
| 2. | 153,006 | $556,942 | 0.01% | |
| 3. | 169,156 | $519,309 | 0% | |
| 4. | 117,805 | $361,661 | 0.04% | |
| 5. | 107,856 | $330,039 | 0% |
News See All
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2026 Earnings Call Transcript
Clint Tomlinson: Good morning, everyone. And welcome to the Anavex Life Sciences Corp. fiscal 2026 first quarter conference call. My name is Clint Tomlinson. I will be your host for today's call.
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q4 2025 Earnings Call Transcript
Clint Tomlinson: Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 Fourth Quarter Conference Call. My name is Clint Tomlinson, and I'll be your host for today's call.
H.C. Wainwright Reiterates Its ‘Buy’ Rating on Anavex Life Sciences Corp. (AVXL) with a $42 Price Target
On September 11, 2025, H.C. Wainwright reiterated its ‘Buy’ rating on Anavex Life Sciences Corp. (NASDAQ:AVXL) with a $42 price target.
10 Best Debt Free Small Cap Stocks to Buy Now
High leverage can be both an advantage and a liability.
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q3 2025 Earnings Call Transcript
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q3 2025 Earnings Call Transcript August 12, 2025Anavex Life Sciences Corp. misses on earnings expectations.
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2025 Earnings Call Transcript
Clint Tomlinson: Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 Second Quarter Conference Call. My name is Clint Tomlinson, and I will be your host for today's call.
10 Low Risk High Reward Stocks Set to Triple by 2030
The market is getting tough these days with increasing interest rates, tense world politics, and inconsistent economic conditions, and investors are constantly looking for opportunities.
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2025 Earnings Call Transcript
Clint Tomlinson: Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 First Quarter Conference Call. My name is Clint Tomlinson, and I will be your host for today's call.
Jim Cramer’s Lightning Rounds: 9 Stocks in Focus
Jim Cramer, the host of Mad Money, recently expressed his concerns about the uncertain economic outlook for 2025, particularly in relation to corporate earnings and the stock market's expectations for...